Evaluation of new iron chelators and their therapeutic potential

被引:48
|
作者
Aouad, F [1 ]
Florence, A [1 ]
Zhang, Y [1 ]
Collins, F [1 ]
Henry, C [1 ]
Ward, RJ [1 ]
Crichton, RR [1 ]
机构
[1] Univ Catholique Louvain, Unite Biochim, B-1348 Louvain, Belgium
关键词
homeostasis; metal ions; chelation;
D O I
10.1016/S0020-1693(02)01040-X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
One of the most important challenges for biological inorganic chemistry is to understand metal ion homeostasis, particularly since we are becoming increasingly aware that its disequilibrium is at the basis of a large number of clinical disorders. It is, therefore, also an important objective of our research to seek solutions, which can alleviate the consequences of the perturbation of the homeostasis of key metal ions within cells, tissues and organisms. Iron is one of the key metals in biology, for which disorders of homeostasis are implicated in a vast panoply of pathological conditions. We review here the ways in which potential iron chelators can be evaluated, using appropriate in vivo or in vitro screening systems, and discuss their potential applications in the chelation of both iron and aluminium in the treatment of a number of human diseases. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:470 / 480
页数:11
相关论文
共 50 条
  • [31] Neurodegenerative diseases and therapeutic strategies using iron chelators
    Ward, Roberta J.
    Dexter, David T.
    Crichton, Robert R.
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2015, 31 : 267 - 273
  • [32] Potential of iron chelators as effective antiproliferative agents
    Richardson, DR
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (10-11) : 1164 - 1180
  • [33] NEW ORALLY ACTIVE IRON CHELATORS
    KONTOGHIORGHES, GJ
    LANCET, 1985, 1 (8432): : 817 - 817
  • [34] Potential Treatment of Retinal Diseases with Iron Chelators
    Shu, Wanting
    Dunaief, Joshua L.
    PHARMACEUTICALS, 2018, 11 (04)
  • [35] Iron chelators as mitophagy agents: Potential and limitations
    Brogyanyi, Tereza
    Kejik, Zdenek
    Vesela, Katerina
    Dytrych, Petr
    Hoskovec, David
    Masarik, Michal
    Babula, Petr
    Kaplanek, Robert
    Pribyl, Tomas
    Zelenka, Jaroslav
    Ruml, Tomas
    Vokurka, Martin
    Martasek, Pavel
    Jakubek, Milan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [36] NEW ORALLY ACTIVE IRON CHELATORS
    KONTOGHIORGHES, GJ
    HOFFBRAND, AV
    HIDER, RC
    HUEHNS, ER
    CHARALAMBOUS, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 567 - 567
  • [37] New aspects in the treatment with iron chelators
    Nolte, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 99 - 99
  • [38] Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators
    Bergeron, RJ
    Wiegand, J
    Wollenweber, M
    McManis, JS
    Algee, SE
    RatliffThompson, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) : 1575 - 1581
  • [39] THE INVITRO AND INVIVO EVALUATION OF HYDROXYPYRIDINONE IRON CHELATORS
    HUEHNS, ER
    PORTER, JB
    HIDER, RC
    HEMOGLOBIN, 1987, 11 (06) : 612 - 612
  • [40] Oral iron chelators: new opportunities and new dilemmas
    Hershko, Chaim
    HAEMATOLOGICA, 2006, 91 (10) : 1307 - 1312